Short-Term Effect of Prebiotics Administration on Stool Characteristics and Serum Cytokines Dynamics in Very Young Children with Acute Diarrhea by Vaisman, Nachum et al.
Nutrients 2010, 2, 683-692; doi:10.3390/nu2070683 
 
 
nutrients 
ISSN 2072-6643 
www.mdpi.com/journal/nutrients 
Article 
Short-Term Effect of Prebiotics Administration on Stool 
Characteristics and Serum Cytokines Dynamics in Very Young 
Children with Acute Diarrhea  
Nachum Vaisman 
1,*,
 Josef Press 
2, Eugene Leibovitz 
3, Güenther Boehm 
4 and Vivian Barak 
5 
1  Unit of Clinical Nutrition, Tel Aviv Sourasky Medical Center, Sackler Faulty of Medicine, Tel Aviv 
University, Tel Aviv, 64239, Israel 
2  Pediatric Emergency Room, Soroka University Medical Center, Beer-Sheva, 84101, Israel; 
E-Mail: press@clalit.org.il 
3  Pediatric Infectious Disease Unit, Soroka University Medical Center, Beer-Sheva, 84111, Israel; 
E-Mail: eugenel@bgu.ac.il 
4  Danone Research Friedrichsdorf, Germany and Sophia Children’s Hospital, Erasmus University, 
Rotterdam, 3015GJ, The Netherlands; E-Mail: Guenther.Boehm@danone.com 
5  Immunology Laboratory for Tumor Diagnosis, Oncology Department, Hadassah-Hebrew University 
Medical Center, Jerusalem, 91120, Israel; E-Mail: barakvivi@hadassah.org.il 
*
  Author to whom correspondence should be addressed: E-Mail: vaisman@tasmc.health.gov.il; 
Tel.: 972-3-6974807, Fax: 972-3-6973973. 
Received: 17 May 2010; in revised form: 18 June 2010 / Accepted: 21 June 2010 / 
Published: 30 June 2010 
 
Abstract: We investigated the effect of a mixture of long-chain fructo-oligosaccharides, 
galacto-oligosaccharides and acidic oligosaccharides on the number and consistency of 
stools and on immune system biomarkers in 104 supplemented and non-supplemented 
subjects (aged 9–24 months) with acute diarrhea. Interleukin-1 (IL-1), IL-1RA, IL-6, IL-8, 
IL-10,  TNF-α and sIL-2R cytokine levels were determined. The significant decrease in 
number of stools and increase in stool consistency in the supplemented group was of little 
clinical relevance. The only significant change in pro- and anti-inflammatory cytokines was 
decreased TNF-α levels in the supplemented group. Prebiotic supplementation during acute 
diarrhea episodes did not influence the clinical course. 
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1. Introduction 
The importance of an intact intestinal microorganism ecosystem is well documented [1]. In breast-fed 
infants, the intestinal microbiota, characterized by a dominance of bifidobacteria [2], is seen as an 
important stimulator of the postnatal development of the intestinal barrier function [3] and of the entire 
immune system [4,5]. It was recently suggested that a modification of the intestinal ecosystem by the 
intake of dietary components such as probiotics [6] and prebiotics [7] could be beneficial. This 
ecosystem is vulnerable to pathogenic bacteria and  viruses, as well as  to drugs, antibiotics and 
laxatives. During diarrhea, pathogens may either grow and colonize the gastrointestinal (GI) tract and 
then invade the host tissues or, alternatively, they may secrete toxins which may disrupt the function of 
the intestinal mucosa, causing nausea, vomiting and diarrhea. Various studies indicated that the 
administration of probiotics to patients with mild-to-moderate diarrhea can reduce the duration of 
diarrhea by about one day [8,9]. The clinical relevance of this reduction, however, is still debatable. 
Prebiotics may also considerably increase the number of specific protective gut microbiota [10], but no 
data are available on the effect of prebiotics on acute diarrhea in humans. Oli et al. [11] showed that 
adding fructo-oligosaccharides (FOS) to an oral electrolyte solution accelerated the recovery of 
bacteria, a reaction perceived as beneficial, in an animal experiment. Brunser et al. [12] studied the 
effect of FOS on the intestinal microbiota during treatment with amoxicillin and reported an increase in 
bifidobacteria in patients receiving prebiotics after seven days of antibiotic treatment compared to a 
control group. These authors reported that the effect of FOS on the occurrence on antibiotic-related 
diarrhea episodes was not significant.  
During the last few years, a prebiotic mixture (90% short-chain galacto-oligosaccharides [scGOS) 
and 10% long-chain FOS (lcFOS)) has been developed as a component in infant formulas. Several 
studies demonstrated that this mixture modulated the entire microbiota closer to the intestinal flora 
composition found in breast-fed infants [13]. In vitro studies demonstrated that these oligosaccharides 
inhibit the adhesion of pathogens to the intestinal epithelial surface [14] and enhance a Th1-dependent 
vaccination response [15], suggesting an anti-infective effect for these oligosaccharides on top of their 
prebiotic effect.  
In animal experiments [15] as well as in human studies [16,17], the amount of time needed in order 
to detect significant effect of prebiotics on gut microbiota was at least two weeks, indicating that a 
preventative  approach  could be more relevant than a  therapeutic  approach.  The objectives of the 
current work were to study the possibility of modifying the course of diarrhea in infants and young 
children  by daily supplementation of a prebiotic mixture of neutral (GOS, FOS) and acidic 
oligosaccharides (AOS) during the first 10 days of diarrhea, and also to investigate the dynamics of 
interleukin-1 (IL-1), IL-1RA, IL-6, IL-8, IL-10, TNF-α, and sIL-2R serum secretion in response to  
this supplementation. Nutrients 2010, 2                                       
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2. Materials and Methods 
2.1. Study Population and Study Design 
This was a prospective, randomized, double blind placebo-controlled study performed in  
2006–2007 at the Pediatric Emergency Room of the Soroka University Medical Center (Beer-Sheva, 
Israel),  where around 60 cases of acute gastroenteritis are seen each month (EL, personal 
communication). The study was supported by a grant from Danone Research. Parents of infants aged 
between nine months and two years who had been admitted to the emergency services due to acute 
diarrhea signed a consent form for their child’s enrollment into this study. Inclusion criteria were no 
previous history of milk protein allergy or antibiotic treatment, or no chronic GI problems. The study 
was approved by the hospital ethics committee.  
Stool cultures were performed at admission. Each child was started on a food supplement consisting 
of  three  2-g sachets  per day of either maltodextrin (placebo) or a mixture of 80% neutral 
oligosaccharides (GOS and FOS in a ratio of 9:1) [12], and 20% AOS derived from cleavage of   
pectin [11]. The supplement was to be taken with three daily meals (a total of 6 g/day). The parents 
were asked to return to the emergency room with their child on days 2–3, 4–5 and 9–12 after 
enrollment and to complete a questionnaire on the number of stools and stool consistency (stool 
consistency scored from 1–5, with 1 = watery, 2 = watery with material, 3 = soft, 4 = formed, regular 
consistency and 5 = hard). On visits 1 and 2 (days 0 and 2–3), blood was drawn for determination of 
serum cytokine concentrations.  
2.2. Analytical Methods  
Serum levels of the tested cytokines (TNF-α, sIL-2R, IL-1, IL-1RA, IL-6, IL-8 and IL-10) were 
measured by a solid phase ELISA. A high-sensitive immunoassay kit (Quantikine HS R&D system, 
Minneapolis, MN 55413, USA) was used. This kit employs an amplification system in which the 
alkaline phosphatase reaction provides a cofactor that activates a redox cycle leading to the formation 
of a colored product. The secondary enzyme system consists of alcohol dehydrogenase and diaphorase 
(Amplifier). Fecal microbiota were analyzed from fresh stool samples  by conventional plating 
techniques. The results were expressed as mean ± 1 standard error (S.E.). 
2.3. Statistical Analysis 
The changes in cytokine levels were examined in three ways: (a) difference between day 0 and day 
2–3 levels, (b) percentage of the individual change in concentration divided by admission levels, and 
(c) dichotomously (i.e., an increase vs. no change or a decrease). Comparisons between the two groups 
of patients (non-supplemented vs. supplemented) with regard to gender, age, height, number of stools, 
serum white blood cell  and  lymphocyte  counts,  neutrophil percentages and serum cytokine 
concentrations were performed using unpaired t-tests, Mann-Whitney and Chi-square tests, as 
appropriate. Comparisons  between the two groups with regard to the number of stools and stool 
consistency over time were by an analysis of variance (ANOVA) with repeated measures. Contrast 
analysis was used to compare each time point vis-a-vis time of admission. The changes in cytokine Nutrients 2010, 2                                       
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concentrations over the first  2–3 days were expressed as a relative percentage change from the 
admission concentrations (cytokine day 2–3- cytokine admission/ cytokine admission%). Significance was set at 
≤0.05. The SPSS (Chicago, IL) for Windows software, Version 13.0 was used for the analysis. A 
mixed model analysis was performed using the SAS for Windows, version 9.1. 
3. Results 
A total of 119 subjects with acute diarrhea were originally enrolled, but only 104 received the food 
supplementation due to either referral to hospitalization from the emergency services or withdrawal of 
consent during the first 24 hours (Figure 1). Out of these 104 patients, 74, 55 and 42 attended visits 2, 
3 and 4, respectively (Figure 1). The characteristics of the study participants' evaluated at enrollment 
are presented in Table 1. 
Figure 1. Study flow-sheet: subjects' characteristics and distribution at the follow–up visits. 
 
 
Table 1. Patients and stool characteristics upon admission. NS = not significant. 
Characteristic  Non-
supplemented 
Supplemente
d 
P- 
value 
Age, months  15.3 ± 9.1  14.5 ± 7.7  NS 
Number stools/d  7.34 ± 3.28  6.84 ± 4.41  NS 
WBC  11.91 ± 4.30  12.13 ± 4.53  NS 
Lymphocytes, %  44.48 ± 17.12  39.58 ± 16.01  NS 
Granulocytes, %  49.54 ± 19.03  53.17 ± 16.92  NS Nutrients 2010, 2                                       
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Table 1. Cont. 
IL6, pg/mL  32.04 ± 58.21  28.76 ± 57.80  NS 
IL8, pg/mL  108.38 ± 110.54  136.21 ± 204.84  NS 
IL10, pg/mL  18.86 ± 21.91  16.74 ± 20.40  NS 
sIL-2R, units/mL  5304.61 ± 
1744.67 
5936.91 ± 
3131.87 
NS 
TNF-α, pg/mL  22.76 ± 8.27  25.55 ± 11.74  NS 
IL1-RA, pg/mL  12062 ± 20910  14316 ± 18742  NS 
IL1-HS, pg/mL  3.22 ± 3.04  5.17 ± 5.34  NS 
 
There were no significant group differences for the various studied parameters. Stool cultures were 
negative in 42 (82.6%) children in the non-supplemented group and in 56 (75.9%) of the children in 
the prebiotic-supplemented group. Stools were positive for Campylobacter jejunii  in three non-
supplemented children compared to two supplemented children and for Shigella flexnerii in one and 
five, respectively. The stools were not analyzed for the presence of rotavirus or enteroviruses. 
The number of stools tended to decrease in both groups during the study period and there were no 
significant differences between the groups at any of the selected time points (3.1 ± 1.1 stools/day in the 
non-supplemented group vs. 3.3  ±  2.0 stools/day in the supplemented group reported at visit 2,   
2.7 ± 1.2 vs. 2.4 ± 1.6 reported at visit 3 and 2.3 ± 1.4 vs. 2.1 ± 1.7 reported at visit 4, respectively, 
two-way ANOVA, P = 0.66). Stool consistency increased significantly in both groups during the study 
period and was significantly higher in the supplemented group (1.8 ± 0.4 vs. 1.8 ± 1.1 in the non-
supplemented and the supplemented group, respectively, reported at visit 2, 2.4 ± 1.1 vs. 2.7 ± 1.1 
reported at visit 3 and 3.0 ± 1.1 vs. 3.4 ± 1.2 reported at visit 4, respectively P = 0.048) (Figure 2). 
Figure 2. Stool consistency in the two groups over the study period (based on parents' 
scores from 1 = watery stools to 5 = hard consistency). 
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No significant group differences in cytokine serum levels were found at enrollment (Table 1). The 
cytokine levels changed in all subjects over the first 2–3 days after admission, but the changes were not 
different between the groups, either in absolute numbers or as a relative change, except for a borderline 
significant relative change in absolute levels for IL-6 (P = 0.064), indicating a larger decrease in the 
non-supplemented group. When the subjects with positive bacterial stool cultures were excluded from 
the analysis, the relative changes in cytokine levels were significantly different for IL-6 (P = 0.043). 
Since the changes in each group were not uniformly increased, unchanged or decreased, a further 
dichotomous analysis was done for comparing the percentage of subjects who had a relative increase 
versus no relative change or a relative decrease in serum levels of the different cytokines during the 
first 2–3 days. The results of the dichotomous analysis indicated that the relative changes in TNF-α 
concentrations were statistically different between the two groups, with less increase and more 
decrease in the supplemented group (P = 0.018) (Figure 3), while the change in IL-1 was of borderline 
significance (P = 0.063), with more increase and less decrease in the values in the supplemented group. 
Cytokines were also grouped as pro-inflammatory (IL-6, IL-8, TNF-α and IL-1) and anti-inflammatory 
(IL-1RA, IL-10), but no significant differences were found between these groups.  
Figure 3. Changes in tumor necrosis factor (TNF-α) levels in each group over the first 48 
hours of supplementation. Non-supplemented (N); supplemented (P). 
 
 
4. Discussion 
Our results indicate that supplementation of prebiotics to the diet of children with acute diarrhea has 
no significant effect on stool characteristics over the first 10 days of treatment. In fact, data from 
animals [15] and preterm infants [16,17] indicate that at least 14 days are necessary in order to develop 
the desired intestinal microbiota. Thus, prebiotics reacting via the development of the intestinal 
microbiota can preferentially be used for prevention rather than for treatment.  Nutrients 2010, 2                                       
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The next question which was examined in the present study was the value of supplementary 
prebiotics for influencing the inflammatory process associated with acute diarrhea, as indicated by 
dynamic changes in cytokine production. Our results do not indicate a significant effect of prebiotics 
on the cytokine profile during the first 2–3 days of treatment. IL-6 tended to decrease while other 
cytokines, including some pro-inflammatory ones, such as IL-8 and TNF-α, continued to increase 
during the first days of diarrhea. No differences were found between the cytokine serum levels of 
patients treated with a supplementation of prebiotics and those not treated, nor when the different 
cytokines were sub-grouped as pro- or anti-inflammatory. The change in IL-6 became significantly 
different when the patients with bacterial gastroenteritis were excluded. Previous studies, published by 
us [17] and others [18], demonstrated a wide variability in the levels of serum cytokines along the 
disease course. In some of the patients included in this study, the cytokine levels continued to increase 
while it had already started to decrease in others to the extent that it was not possible to group the 
patients. In order to overcome this problem, one of our inclusion criteria was a duration of symptoms 
of less than 48 hours before the first visit to the emergency room. Nevertheless, a large variability in 
magnitude and direction of cytokine secretion was found in these patients as well. In an experimental 
study, Hesse et al. suggested that serum cytokines appear in a temporal sequence after endotoxin 
injection [19]. With this in mind, we further divided each group dichotomously according to the 
percentage of subjects who had an increase, no change or a decrease in the levels of different cytokines 
over the first 2–3 days of treatment. The TNF-α level decreased significantly more in the supplemented 
group (P = 0.018) (Figure 3), but the IL-1 level showed a borderline decrease in the non-supplemented 
group (P = 0.063). Since TNF-α is an important pro-inflammatory cytokine, this finding may be of 
clinical importance.  
Different meta-analyses have recently been published on the role of probiotic strains on the course 
of acute diarrhea [20,21]. Their results showed an overall reduction of one day in the duration of 
diarrhea in mild-to-moderate episodes but no demonstrable benefit in the more severe cases [22]. The 
effect was different for different bacterial strains. For example, supplementation with Lactobacillus 
paracasei strain ST11 had no effect on rotavirus diarrhea [23], while Lactobacillus rhamnousus did 
shorten the duration of rotavirus diarrhea but not the diarrhea caused by other pathogens [24]. A recent 
Cochrane review on the role of probiotics for the prevention of pediatric antibiotic-associated diarrhea 
(AAD) concluded that probiotics show promise for the prevention of AAD, but the findings were 
considered too premature for routinely recommending it for prevention [21]. 
The acute effect of prebiotics in acute diarrhea has not been previously studied. While promising 
results were found in animal models by using prebiotics to change gut microbiota and prevent AAD, 
there was no report of successful preventive or therapeutic use of prebiotics in patients with diarrhea 
and/or inflammatory diseases of the gut [25]. In antibiotic-associated diarrhea, oligo-fructans prevented 
further episodes of diarrhea in patients with C. difficile-associated symptoms treated with 
metronidazole and vancomycin: this was not found in hospital-based elderly people who were 
prescribed broad-spectrum antibiotics and received FOS during therapy [26]. Supplementing children 
aged 1–2 years with a mixture of FOS and inulin after one week of amoxicillin therapy increased fecal 
bifidobacteria on day 7 of treatment without any apparent change in diarrheal symptoms [11]. Previous 
publications indicated a possible effect of prebiotics on the immunological response [27-29]. Our Nutrients 2010, 2                                       
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results did indicate some changes in the cytokine profile: this is intriguing and warrants looking into in 
order to further explore the inflammatory response associated with acute diarrhea.  
In conclusion, our results showed no significant clinical effect of prebiotic administration during 
acute diarrhea episodes in children aged 1–2 years. The changes we did observe in cytokine production 
should be further investigated in order to clarify whether or not prebiotics have any short-term effect in 
modifying the inflammatory process which accompanies episodes of acute diarrhea.  
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